rs397514700
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_032208.3(ANTXR1):c.505C>T(p.Arg169Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,816 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_032208.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANTXR1 | NM_032208.3 | c.505C>T | p.Arg169Ter | stop_gained | 7/18 | ENST00000303714.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANTXR1 | ENST00000303714.9 | c.505C>T | p.Arg169Ter | stop_gained | 7/18 | 1 | NM_032208.3 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461816Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727208
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
GAPO syndrome Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | May 02, 2013 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 01, 2017 | The p.Arg169X (NM_032208.2 c.505C>T) variant in ANTXR1 has been reported in 1 ho mozygous individual with growth delay alopecia pseudoanodontia-optic atrophy syn drome (GAPO) (Stranecky 2013), and was absent from large population studies. Cel l lines from this published case provide evidence supporting that this variant c auses GAPO syndrome (reduced RT-PCR products, reductions in relative cDNA expres sion, absence of protein from skin fibroblasts by immunoblot, and alterations in actin cytoskeleton network by immunofluorescence) (Stranecky 2013). This nonsen se variant leads to a premature termination codon at position 169, which is pred icted to lead to a truncated or absent protein. Biallelic loss of function of th e ANTXR1 gene has been associated with GAPO syndrome. In summary, the p.Arg169X variant in ANTXR1 gene is likely pathogenic for GAPO syndrome in an autosomal r ecessive manner based on case report, absence in controls and functional evidenc e. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at